13th Annual Biomarkers Congress
February 15 - 16, 2018 - Manchester UKOxford Global
a.fernandez@oxfordglobal.co.uk
Phone:1865248455
Oxford Global are proud to present the 13th Annual Biomarkers & Precision Medicine Congress taking place on 15-16 February 2018 in Manchester, UK. Over 300 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions Over 55 presentations, case studies, novel technologies, round-table and panel discussions focused on the opportunities and challenges of biomarker research discovery and development in a variety of therapeutic areas such as immune-oncology, neuroscience and cardio vascular disease areas, precision medicine, companion diagnostics, data integration methods, and utilising biomarkers in clinical trials View Agenda here: http://bit.ly/1QBxjGv New for 2018 – Gain novel insights into reimbursement, stakeholders and regulatory approval in biomarkers 6 Interactive Streams: • Biomarkers in Drug Discovery & Development Therapeutic Areas: Autoimmune, Immuno-oncology, Neuroscience, Oncology • Precision Medicine, Companion Diagnostics, Molecular Diagnostics Development • Biomarkers in Drug Discovery & Development Therapeutic Areas: Cardiovascular, Rheumatology, Respiratory, COPD, Rare Diseases, Infectious Diseases, Inherited Diseases • Innovations in Biomarkers Research, Assay Development, Imaging, Data Integration Methods, Bioinformatics, Trial Design • Biomarker: Clinical Development & Clinical Trials • Innovative Biology- NGS & Genomic Markers, Clinical Testing and Diagnostics Development 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities This event will be co-located 5th Annual Biomarker in Clinical Development Congress For further information and prices please contact a.fernandez@oxfordglobal.co.uk . Alternatively, please click here: http://bit.ly/1QBxjGv